Skip to content

FDA Inspection

Regulatory

Also known as: FDA audit, FDA facility inspection, 483 inspection

An FDA investigator's on-site examination of a manufacturing facility.

What It Means

FDA inspections are on-site examinations of manufacturing facilities by FDA investigators. Inspections can be routine (scheduled), for-cause (triggered by complaints, adverse events, or import alerts), or pre-approval. Findings are documented on FDA Form 483 ('Inspectional Observations'). Serious or uncorrected findings can lead to Warning Letters, import alerts, injunctions, or seizures. FDA inspection history is public record.

What It Is Not

An FDA inspection is NOT FDA approval. A facility can be inspected and receive multiple 483 observations while still operating legally. Conversely, absence of recent FDA inspection does not mean the facility is compliant — FDA cannot inspect all facilities regularly. Companies that highlight 'no 483 observations' may simply not have been inspected recently.

Related Categories

Need Help Understanding Compliance?

Our directory connects you with manufacturers and labs that meet these standards.